Abstract
The advent of next-generation sequencing (NGS) technologies had seen rapid adoption by clinical laboratories. Herein, we report the clinical validation data of a laboratory developed test-APEX Tissue (MiRXES), which enables simultaneous detection of single-nucleotide variants (SNVs), insertions/deletions (InDels), copy number amplifications and fusions through both DNA and RNA sequencing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
